CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
Kai Vogt
Advertisement
Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma.
Articles by Kai Vogt
Advertisement
Latest Updated Articles
- Digitalization: A CDMO’s Perspective
Published: February 15th 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
